TNF Pharmaceuticals, Inc.

TNF Pharmaceuticals, Inc.verified

TNFA

Price:

$5.2

Market Cap:

$9.18M

TNF Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company. It focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and ...[Read more]

Industry

Biotechnology

IPO Date

2014-01-23

Stock Exchange

NASDAQ

Ticker

TNFA

The PE Ratio as of November 2025 (TTM) for TNF Pharmaceuticals, Inc. (TNFA) is -0.03

According to TNF Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.03. This represents a change of -93.26% compared to the average of -0.38 of the last 4 quarters.

TNF Pharmaceuticals, Inc. (TNFA) Historical PE Ratio (quarterly & annually)

How has TNFA PE Ratio performed in the past?

The mean historical PE Ratio of TNF Pharmaceuticals, Inc. over the last ten years is -0.11. The current -0.03 PE Ratio has changed 2.21% with respect to the historical average. Over the past ten years (40 quarters), TNFA's PE Ratio was at its highest in in the September 2023 quarter at 0.18. The PE Ratio was at its lowest in in the September 2024 quarter at -0.51.

Quarterly (TTM)
Annual

Average

-0.11

Median

-0.01

Minimum

-0.74

Maximum

-0.00

TNF Pharmaceuticals, Inc. (TNFA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of TNF Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 545.03%

Maximum Annual PE Ratio = -0.00

Minimum Annual Increase = -83.71%

Minimum Annual PE Ratio = -0.74

Quarterly (TTM)
Annual
YearPE RatioChange
2024-0.12-83.71%
2023-0.74352.83%
2022-0.16118.07%
2021-0.07484.29%
2020-0.01154.78%
2019-0.01274.48%
2018-0.00545.03%
2017-0.00-28.25%
2016-0.00252.35%
2015-0.00-66.42%

TNF Pharmaceuticals, Inc. (TNFA) Average PE Ratio

How has TNFA PE Ratio performed in the past?

The current PE Ratio of TNF Pharmaceuticals, Inc. (TNFA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.34

5-year avg

-0.22

10-year avg

-0.11

TNF Pharmaceuticals, Inc. (TNFA) PE Ratio vs. Peers

How is TNFA’s PE Ratio compared to its peers?

TNF Pharmaceuticals, Inc.’s PE Ratio is greater than Channel Therapeutics Corporation (-0.10), greater than CervoMed Inc. (-3.59), less than IMV Inc. (-0.00), greater than Apexigen, Inc. (-0.24), greater than Cyclacel Pharmaceuticals, Inc. (-0.25), greater than COSCIENS Biopharma Inc. (-0.34), greater than Tvardi Therapeutics, Inc. (-2.81), greater than Turnstone Biologics Corp. (-0.17), greater than Omega Therapeutics, Inc. (-0.24), greater than Biora Therapeutics, Inc. (-0.07),

Build a custom stock screener for TNF Pharmaceuticals, Inc. (TNFA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TNF Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TNF Pharmaceuticals, Inc. (TNFA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TNF Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is TNF Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for TNF Pharmaceuticals, Inc. (TNFA)?

What is the highest PE Ratio for TNF Pharmaceuticals, Inc. (TNFA)?

What is the 3-year average PE Ratio for TNF Pharmaceuticals, Inc. (TNFA)?

What is the 5-year average PE Ratio for TNF Pharmaceuticals, Inc. (TNFA)?

How does the current PE Ratio for TNF Pharmaceuticals, Inc. (TNFA) compare to its historical average?